BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 33632753)

  • 1. Study protocol for investigating the performance of an automated blood test measuring GFAP and UCH-L1 in a prospective observational cohort of patients with mild traumatic brain injury: European BRAINI study.
    Richard M; Lagares A; Bondanese V; de la Cruz J; Mejan O; Pavlov V; Payen JF;
    BMJ Open; 2021 Feb; 11(2):e043635. PubMed ID: 33632753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study protocol for investigating the clinical performance of an automated blood test for glial fibrillary acidic protein and ubiquitin carboxy-terminal hydrolase L1 blood concentrations in elderly patients with mild traumatic BRAIN Injury and reference values (BRAINI-2 Elderly European study): a prospective multicentre observational study.
    Lagares A; Payen JF; Biberthaler P; Poca MA; Méjan O; Pavlov V; Viglino D; Sapin V; Lassaletta A; de la Cruz J;
    BMJ Open; 2023 Jul; 13(7):e071467. PubMed ID: 37460257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of glial fibrillary acidic protein (GFAP) and ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) biomarkers in predicting CT scan results and neurological outcomes in children with traumatic brain injury (BRAINI-2 paediatric study): protocol of a European prospective multicentre study.
    Lorton F; Lagares A; de la Cruz J; Méjan O; Pavlov V; Sapin V; Poca MA; Lehner M; Biberthaler P; Chauviré-Drouard A; Gras-Le-Guen C; Scherdel P; ;
    BMJ Open; 2024 May; 14(5):e083531. PubMed ID: 38754888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time Course and Diagnostic Accuracy of Glial and Neuronal Blood Biomarkers GFAP and UCH-L1 in a Large Cohort of Trauma Patients With and Without Mild Traumatic Brain Injury.
    Papa L; Brophy GM; Welch RD; Lewis LM; Braga CF; Tan CN; Ameli NJ; Lopez MA; Haeussler CA; Mendez Giordano DI; Silvestri S; Giordano P; Weber KD; Hill-Pryor C; Hack DC
    JAMA Neurol; 2016 May; 73(5):551-60. PubMed ID: 27018834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of Serum Biomarkers in the Diagnosis and Stratification of Mild Traumatic Brain Injury.
    Lewis LM; Schloemann DT; Papa L; Fucetola RP; Bazarian J; Lindburg M; Welch RD
    Acad Emerg Med; 2017 Jun; 24(6):710-720. PubMed ID: 28170122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Glial and Neuronal Blood Biomarkers Compared With Clinical Decision Rules in Assessing the Need for Computed Tomography in Patients With Mild Traumatic Brain Injury.
    Papa L; Ladde JG; O'Brien JF; Thundiyil JG; Tesar J; Leech S; Cassidy DD; Roa J; Hunter C; Miller S; Baker S; Parrish GA; Davison J; Van Dillen C; Ralls GA; Briscoe J; Falk JL; Weber K; Giordano PA
    JAMA Netw Open; 2022 Mar; 5(3):e221302. PubMed ID: 35285924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between Blood and Computed Tomographic Imaging Biomarkers in a Cohort of Mild Traumatic Brain Injury Patients.
    Chen H; Ding VY; Zhu G; Jiang B; Li Y; Boothroyd D; Rezaii PG; Bet AM; Paulino AD; Weber A; Glushakova OY; Hayes RL; Wintermark M
    J Neurotrauma; 2022 Oct; 39(19-20):1329-1338. PubMed ID: 35546284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of day-of-injury plasma GFAP and UCH-L1 concentrations for predicting functional recovery after traumatic brain injury in patients from the US TRACK-TBI cohort: an observational cohort study.
    Korley FK; Jain S; Sun X; Puccio AM; Yue JK; Gardner RC; Wang KKW; Okonkwo DO; Yuh EL; Mukherjee P; Nelson LD; Taylor SR; Markowitz AJ; Diaz-Arrastia R; Manley GT;
    Lancet Neurol; 2022 Sep; 21(9):803-813. PubMed ID: 35963263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study.
    Bazarian JJ; Biberthaler P; Welch RD; Lewis LM; Barzo P; Bogner-Flatz V; Gunnar Brolinson P; Büki A; Chen JY; Christenson RH; Hack D; Huff JS; Johar S; Jordan JD; Leidel BA; Lindner T; Ludington E; Okonkwo DO; Ornato J; Peacock WF; Schmidt K; Tyndall JA; Vossough A; Jagoda AS
    Lancet Neurol; 2018 Sep; 17(9):782-789. PubMed ID: 30054151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of Acute and Subacute Blood Biomarkers to Assist Diagnosis in CT-Negative Isolated Mild Traumatic Brain Injury.
    Reyes J; Spitz G; Major BP; O'Brien WT; Giesler LP; Bain JWP; Xie B; Rosenfeld JV; Law M; Ponsford JL; O'Brien TJ; Shultz SR; Willmott C; Mitra B; McDonald SJ
    Neurology; 2023 Nov; 101(20):e1992-e2004. PubMed ID: 37788938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Effectiveness of Blood-Based Brain Biomarkers for Screening Adults with Mild Traumatic Brain Injury in the French Health Care Setting.
    Zimmer L; McDade C; Beyhaghi H; Purser M; Textoris J; Krause A; Blanc E; Pavlov V; Earnshaw S
    J Neurotrauma; 2023 Apr; 40(7-8):706-719. PubMed ID: 36267001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glial Fibrillary Acidic Protein (GFAP) Outperforms S100 Calcium-Binding Protein B (S100B) and Ubiquitin C-Terminal Hydrolase L1 (UCH-L1) as Predictor for Positive Computed Tomography of the Head in Trauma Subjects.
    Mahan MY; Thorpe M; Ahmadi A; Abdallah T; Casey H; Sturtevant D; Judge-Yoakam S; Hoover C; Rafter D; Miner J; Richardson C; Samadani U
    World Neurosurg; 2019 Aug; 128():e434-e444. PubMed ID: 31051301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Levels of Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 During the First Week After a Traumatic Brain Injury: Correlations With Clinical and Imaging Findings.
    Posti JP; Takala RS; Runtti H; Newcombe VF; Outtrim J; Katila AJ; Frantzén J; Ala-Seppälä H; Coles JP; Hossain MI; Kyllönen A; Maanpää HR; Tallus J; Hutchinson PJ; van Gils M; Menon DK; Tenovuo O
    Neurosurgery; 2016 Sep; 79(3):456-64. PubMed ID: 26963330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex differences in time course and diagnostic accuracy of GFAP and UCH-L1 in trauma patients with mild traumatic brain injury.
    Papa L; Brophy GM; Alvarez W; Hirschl R; Cress M; Weber K; Giordano P
    Sci Rep; 2023 Jul; 13(1):11833. PubMed ID: 37481589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 Using a Rapid Point of Care Test for Predicting Head Computed Tomography Lesions After Mild Traumatic Brain Injury in a Dutch Multi-Center Cohort.
    Chayoua W; Visser K; de Koning ME; Beishuizen A; IJmker R; van der Naalt J; Krabbe JG; van der Horn HJ
    J Neurotrauma; 2024 Feb; ():. PubMed ID: 38326742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal Biomarker Ubiquitin C-Terminal Hydrolase Detects Traumatic Intracranial Lesions on Computed Tomography in Children and Youth with Mild Traumatic Brain Injury.
    Papa L; Mittal MK; Ramirez J; Silvestri S; Giordano P; Braga CF; Tan CN; Ameli NJ; Lopez MA; Haeussler CA; Mendez Giordano D; Zonfrillo MR
    J Neurotrauma; 2017 Jul; 34(13):2132-2140. PubMed ID: 28158951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of a rapid glial fibrillary acidic protein/ubiquitin carboxyl-terminal hydrolase L1 test for the prediction of intracranial injuries on head computed tomography after mild traumatic brain injury.
    Bazarian JJ; Welch RD; Caudle K; Jeffrey CA; Chen JY; Chandran R; McCaw T; Datwyler SA; Zhang H; McQuiston B
    Acad Emerg Med; 2021 Nov; 28(11):1308-1317. PubMed ID: 34358399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein.
    Diaz-Arrastia R; Wang KK; Papa L; Sorani MD; Yue JK; Puccio AM; McMahon PJ; Inoue T; Yuh EL; Lingsma HF; Maas AI; Valadka AB; Okonkwo DO; Manley GT;
    J Neurotrauma; 2014 Jan; 31(1):19-25. PubMed ID: 23865516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling the Kinetics of Serum Glial Fibrillary Acidic Protein, Ubiquitin Carboxyl-Terminal Hydrolase-L1, and S100B Concentrations in Patients with Traumatic Brain Injury.
    Welch RD; Ellis M; Lewis LM; Ayaz SI; Mika VH; Millis S; Papa L
    J Neurotrauma; 2017 Jun; 34(11):1957-1971. PubMed ID: 28031000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study.
    Mondello S; Papa L; Buki A; Bullock MR; Czeiter E; Tortella FC; Wang KK; Hayes RL
    Crit Care; 2011 Jun; 15(3):R156. PubMed ID: 21702960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.